Loading...
Derniers dépôts
-
Clément Delmas, François Roubille, Nicolas Lamblin, Laurent Bonello, Guillaume Leurent, et al.. Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry. ESC Heart Failure, 2022, 9 (1), pp.408-419. ⟨10.1002/ehf2.13734⟩. ⟨hal-03506382v2⟩
-
Devaprakash Manoharan, Sivakumar Natesan, Muriel Billamboz, Samir Jawhara. Role of Bacteria-Derived Exopolysaccharides in Inflammatory Bowel Disease with a Special Focus on Cyanobacterial Exopolysaccharides. Advances in Applied Microbiology, 2024, 4 (1), pp.250-274. ⟨10.3390/applmicrobiol4010017⟩. ⟨hal-04454375⟩
-
Marius Trøseid, José Arribas, Lambert Assoumou, Aleksander Rygh Holten, Julien Poissy, et al.. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial. Critical Care, 2023, 27 (1), pp.9. ⟨10.1186/s13054-022-04205-8⟩. ⟨hal-04399266⟩
-
Miguel Seral-Cortes, Sergio Sabroso-Lasa, Pilar de Miguel-Etayo, Marcela Gonzalez-Gross, Eva Gesteiro, et al.. Development of a Genetic Risk Score to predict the risk of overweight and obesity in European adolescents from the HELENA study. Scientific Reports, 2021, 11 (1), pp.3067. ⟨10.1038/s41598-021-82712-4⟩. ⟨hal-04172535⟩